Joshua Pinto
CIK: 0001992595
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (38 total)
- Aug 20, 2026NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
500K shares- - Feb 17, 2026NMRA
Neumora Therapeutics, Inc.
Sale(S)Direct6K shares at avg. $3.54$21K - Jan 8, 2026NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.2M shares- - Nov 13, 2025MTSR
Metsera, Inc.
Award(A)DirectRestricted Stock Unit
2.7K shares- - Nov 13, 2025MTSR
Metsera, Inc.
Disposition(D)Direct2.7K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
720.1K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
170K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
223K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
270.8K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
223K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
127.4K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
3M shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
170K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
127.4K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
720.1K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
223K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
270.8K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
223K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
3M shares- - May 22, 2025MTSR
Metsera, Inc.
Gift(G)IndirectStock Option (Right to Buy)
149K shares- - May 22, 2025MTSR
Metsera, Inc.
Gift(G)DirectStock Option (Right to Buy)
149K shares- - May 21, 2025NMRA
Neumora Therapeutics, Inc.
Gift(G)Direct13.2K shares- - May 21, 2025NMRA
Neumora Therapeutics, Inc.
Gift(G)Indirect13.2K shares- - May 20, 2025MTSR
Metsera, Inc.
Award(A)DirectStock Option (Right to Buy)
16.1K shares- - Feb 18, 2025NMRA
Neumora Therapeutics, Inc.
Sale(S)Direct8K shares at avg. $1.67$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 20, 2026 |  NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Feb 17, 2026 | NMRA Neumora Therapeutics, Inc. | Sale(S) | 5,967 | $3.54 | $21,093 | Direct |
| Jan 8, 2026 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,200,000 | - | - | Direct |
| Nov 13, 2025 |  MTSR Metsera, Inc. | Award(A) Restricted Stock Unit | 2,688 | - | - | Direct |
| Nov 13, 2025 | MTSR Metsera, Inc. | Disposition(D) | 2,688 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 720,084 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 170,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 223,034 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 270,828 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 223,034 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 127,448 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 3,000,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 170,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 127,448 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 720,084 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 223,034 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 270,828 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 223,034 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 3,000,000 | - | - | Direct |
| May 22, 2025 | MTSR Metsera, Inc. | Gift(G) Stock Option (Right to Buy) | 148,953 | - | - | Indirect |
| May 22, 2025 | MTSR Metsera, Inc. | Gift(G) Stock Option (Right to Buy) | 148,953 | - | - | Direct |
| May 21, 2025 | NMRA Neumora Therapeutics, Inc. | Gift(G) | 13,202 | - | - | Direct |
| May 21, 2025 | NMRA Neumora Therapeutics, Inc. | Gift(G) | 13,202 | - | - | Indirect |
| May 20, 2025 | MTSR Metsera, Inc. | Award(A) Stock Option (Right to Buy) | 16,125 | - | - | Direct |
| Feb 18, 2025 | NMRA Neumora Therapeutics, Inc. | Sale(S) | 8,048 | $1.67 | $13,477 | Direct |
1-25 of 38 transactions
About Pinto Joshua
Pinto Joshua (SEC CIK 0001992595) files insider reports with the SEC as President & CEO of Neumora Therapeutics, Inc. (NMRA) and Director of Metsera, Inc. (MTSR).
Signal8 holds 10 ownership filings by Pinto Joshua (1 Form 3, 9 Form 4), filed between Jan 30, 2025 and Aug 21, 2026. Those filings report 38 transactions, from Feb 13, 2025 to Aug 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pinto Joshua's filings is in WATERTOWN, MA.
Recent filings by Pinto Joshua
- Aug 20, 2026: Grant or award of NMRA derivative securities (Form 4, code A).
- Feb 17, 2026: Open-market sale of NMRA shares (Form 4, code S).
- Jan 8, 2026: Grant or award of NMRA derivative securities (Form 4, code A).
- Nov 13, 2025: Grant or award of MTSR derivative securities (Form 4, code A).
- Nov 13, 2025: Disposition to issuer transaction of MTSR shares (Form 4, code D).